SCHEMBL6155236

SCHEMBL6155236

CCCc1nnc(C(Cc2ccc(-c3cccc(C(CC(C)C)NC(=O)O)c3)cc2)Nc2ccccc2C(=O)c2ccccc2)o1

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.40
PPARA Q07869 3/20 0.40
PPARD Q03181 1/20 0.40
ADAMTS4 O75173 1/20 0.37
ADAMTS5 Q9UNA0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2855544 0.84 PPARG (0.43) PPARGPPARAPPARDADAMTS4ADAMTS5
SCHEMBL2855546 0.84 PPARG (0.43) PPARGPPARAPPARDADAMTS4ADAMTS5
SCHEMBL2856120 0.82 PPARG (0.40) PPARGPPARAPPARDADAMTS4ADAMTS5
SCHEMBL2853877 0.82 PPARG (0.39) PPARGPPARAPPARDADAMTS4ADAMTS5
SCHEMBL2853874 0.82 PPARG (0.41) PPARGPPARAPPARDADAMTS4ADAMTS5
SCHEMBL2856957 0.81 PPARG (0.44) PPARGPPARAPPARDADAMTS4ADAMTS5
SCHEMBL2856242 0.81 PPARG (0.44) PPARGPPARAPPARDADAMTS4ADAMTS5
SCHEMBL6155894 0.78 PPARG (0.40) PPARGPPARAPPARD
SCHEMBL2852205 0.77 PPARG (0.41) PPARGPPARAPPARD
SCHEMBL2852203 0.77 PPARG (0.41) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575911-A2 BIAROMATIC COMPOUNDS WHICH ACTIVATE PPAR-GAMMA TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS Galderma Research & Development, S.N.C. (FR) 2005-09-21 EP disclosed
WO-2004046091-A2 BIAROMATIC COMPOUNDS WHICH ACTIVATE PPAR-GAMA TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2004-06-03 WO disclosed